Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.
about
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failureAn evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever.Cotrimoxazole treats fluoroquinolone-resistant Salmonella typhi H58 infection.Molecular and Clinical Epidemiology of Salmonella Paratyphi A Isolated from Patients with Bacteremia in Nepal.Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a Salmonella Proteome Array.Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.High Rates of Enteric Fever Diagnosis and Lower Burden of Culture-Confirmed Disease in Peri-urban and Rural Nepal.Emergence of Resistance Mutations in Salmonella enterica Serovar Typhi Against Fluoroquinolones.A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital.Assessment and Translation of the Antibody-in-Lymphocyte Supernatant (ALS) Assay to Improve the Diagnosis of Enteric Fever in Two Controlled Human Infection Models and an Endemic Area of Nepal.Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults.Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing
P2860
Q36318613-BBFF71C7-56B7-458E-B3D3-5E9371684B56Q36723425-B65F77EC-4AD1-4B99-8D52-FB0F95BED6E8Q39532273-BAB0F104-61CD-4983-AC2E-FDAA692DD84EQ40082211-6F3ACC22-5789-48ED-9EF6-319DCD32553DQ41927483-A7F45426-87E0-46D5-8143-D1C07327BD61Q41928306-26A48086-F2CF-465F-B6E8-ED833160D43AQ41928349-11E6E36B-2EDF-4F29-AA0E-2784752D224EQ41928617-80384A6E-090B-4FE2-BC78-ED771826D7C9Q47098299-C90933FD-6F02-4D65-89C9-22AD0F2D34F0Q47108214-DA7F30E8-8A18-4CF7-BD4B-B868282B0A9CQ47136138-F0BC3E8C-E879-42FC-9674-1517A2F72C27Q55026157-BF384ABA-B50A-4847-89F9-ED0E1994F78EQ57945279-6A171118-D768-4CFD-97B8-218A3ABCBBB8
P2860
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@ast
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@en
type
label
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@ast
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@en
prefLabel
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@ast
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@en
P2093
P2860
P50
P1476
Gatifloxacin versus ceftriaxon ...... , randomised controlled trial.
@en
P2093
Abhishek Giri
Amit Arjyal
Bharat Kumar Yadav
Corinne N Thompson
Damodar Gajurel
Dinesh Lamsal
Duy Pham Thanh
Ganesh Shah
Ho Thi Nhan
Kamal Lamsal
P2860
P304
P356
10.1016/S1473-3099(15)00530-7
P50
P577
2016-01-19T00:00:00Z